Search This Blog

Wednesday, June 3, 2026

Lilly RNA editing deal worth up to $1.9B with Ascidian

 Eli Lilly announces a kidney-disease treatment collaboration with Ascidian worth up to $1.9 billion.

https://finviz.com/stock?t=LLY&p=d

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)